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Background: Nausea and vomiting are common and unpleasant complications in pregnancy. Although many alternative therapists 
support the use of ginger for nausea and vomiting of pregnancy, there is currently insufficient clinical evidence to support its use in this 
condition
Objectives: The present study was performed to assess the effectiveness of ginger in the treatment of nausea and vomiting in pregnancy.
Materials and Methods: This seven-day clinical trial was performed on 120 eligible pregnant women with symptoms of mild to moderate 
nausea and vomiting before 16 weeks gestation. They were divided into; ginger, placebo and control groups, by block randomization. 
Women were asked to record their nausea and vomiting for three days, and then participants received either ginger capsules, or a placebo 
for four days. No intervention was done with the control group. Data measure was self-recorded symptoms according to the Rhodes Index. 
Data were analyzed by ANOVA, ANCOVA, Kruskal-Wallis, Chi-square, and Fisher’s exact test, for the quantitative and qualitative variables.
Results: There were no statistical differences in the baseline demographics between the three groups apart from; age of marriage and 
wanted or unwanted pregnancy. An ANCOVA test (covariance test) showed significant differences in mean scores after the intervention in 
the three groups (P < 0.001).
Conclusions: Ginger was effective for the relief of mild to moderate nausea and vomiting in pregnant women at less than 16 weeks 
gestation.
Keywords:Nausea; Vomiting; Pregnancy; Ginger
Implication for health policy/practice/research/medical education:
Ginger is effective in reducing nausea and vomiting in mild to moderate symptomatic pregnant women before 16 weeks gestation. Therefore, obstetri-
cians and midwives may recommend the use of ginger for the relief of this condition in pregnancy.
Copyright © 2014, Kashan University of Medical Sciences; Published by Kowsar Corp. This is an open-access article distributed under the terms of the Creative Com-
mons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Background
Nausea and vomiting are the most prevalent and prob-
ably the most unpleasant complications in pregnancy. It is 
reported by 50% to 80% of pregnant women (1). There is no 
known cause for this problem; however, hormonal changes 
as well as psychological factors may play a role in this con-
dition (2). Approximately, a quarter of all pregnant women 
have to leave their work because of this problem (3). In less 
than 2% of cases, this problem escalates to severe nausea and 
vomiting (hyperemesis gravidarum), and that leads to an im-
balance of water and electrolytes, malnutrition, and loss of 
5% of body weight (4). This condition may result in the mal-
function of different body systems and organs, including the 
kidneys, and an imbalance of water and electrolytes. In addi-
tion, it may also have adverse effects on the fetus (5). Nausea 
and vomiting in pregnancy (NVP) may lead to depression, 
feelings of incompetence, loss of work hours, hospitalization 
and termination of the pregnancy (6). For this reason, an ef-
fective treatment during pregnancy is recommended (7). 
Mothers who experience nausea and vomiting during their 
pregnancy are more likely to experience the same problem 
in their next pregnancy (5). Research results have shown that 
the incidence of NVP in Iran is between 16% to 21.7% (8, 9). 
Antiemetic and non-pharmacological interventions such 
as; acupressure or ginger, are effective in reducing the fre-
quency of nausea and vomiting (2, 10). Ginger is a plant that 
has been used in traditional medicine for the treatment 
of all varieties of nausea and vomiting, including NVP (11). 
The root of the ginger is used to flavor food. In addition, it 
is used to alleviate gastric discomfort. This root is used in 
either fresh or dried powder form (12). Some researchers in 
Iran reported that capsules or biscuits containing ginger 
are effective in the treatment of NVP (13). The exact mecha-
nism of ginger as an antiemetic agent is not known. It seems 
that ginger controls serotonin receptors at the level of the 
digestive system (11). The risks of; congenital abnormalities, 
prenatal mortalities, fetal deaths, low birth weights, and 
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low Apgar scores, do not increase with the use of ginger in 
pregnancy. Such findings are very important for health care 
workers who recommend that their pregnant clients use 
this herbal medicine (14). 
Reports from some studies have shown that ginger can re-
duce the frequency of NVP (1, 13, 15, 16), but there is no agree-
ment about its dosage (1). While the recommended dose in 
Europe and North America is no higher than two grams per 
day, Chinese practitioners prescribe a divided dose of nine 
grams per day (although they rarely use this amount dur-
ing pregnancy] (17). The results of a systematic study have 
mentioned that there are no high-quality studies to support 
the use of ginger during pregnancy (18). In addition, the re-
sults of a study conducted by Lee have demonstrated that 
the use of ginger during pregnancy does not relieve acute 
nausea and vomiting (19). Betz et al. in a systematic study, 
also reported that the use of ginger does not decrease levels 
of nausea and vomiting following an operation (20). 
2. Objectives
Due to the conflicting results in the previous studies and 
recommendations for further studies in this area, this study 
was conducted. The aim of our study was to assess the effect 
of ginger to relieve nausea and vomiting in pregnancy.
3. Materials and Methods
This clinical trial was approved by the Ethical Research 
Committee of Kashan University of Medical Sciences. The 
participants of this study were pregnant women who 
were referred to the Prenatal Care Unit of Naghavi Hospital 
Kashan/Iran. This clinic is the only center that provides pre-
natal care ten hours per day. The inclusion criterion were: 
1) being a volunteer, 2) suffering from nausea and/or mild 
to moderate vomiting, 3) gestational age less than 16 weeks, 
4) singleton pregnancy, 5) reading and writing ability, 6) 
no digestive disease, 7) no history of treatment with other 
anti-vomiting drugs within the last three weeks, and 8) resi-
dency in Kashan. The exclusion criterion included: subjects 
who did not complete the forms, subjects that experienced 
side effects from consuming ginger capsules, subjects who 
were advised that the treatment was not effective and that 
they needed further treatment, and subjects who vomited 
more than five times per day. 
From December 10, 2008 to July 15, 2009, a total of 120 
pregnant women that met the inclusion criterion, were 
selected from 431 patients referring to the prenatal care 
center. After obtaining verbal informed consent, a rou-
tine pregnancy checkup was completed. Then the par-
ticipants were divided into three groups (ginger, placebo 
and control) by using block randomization. All the sub-
jects completed a questionnaire containing demograph-
ic information such as; age, age of marriage, gestational 
age, occupation, parity, wanted or unwanted pregnancy, 
and education level. They were asked to avoid any kind of 
medication except for the one prescribed by the research-
er. The participants were on this regimen for seven days. 
They were recommended to; increase the number of 
meals with less volume, reduce high fat and high carbo-
hydrate foods, avoid foods that trigger nausea and vom-
iting, and to start eating before they felt very hungry. In 
addition, the participants were asked to; avoid smoking, 
have a piece of dried bread when they woke up, refuse 
fried, odorous and spicy foods, avoid gas forming drinks, 
and maintain a suitable position. 
No intervention was made during the first three days 
and then both placebo and ginger groups received four 
days treatment. The ginger group received ginger cap-
sules and the placebo group received lactose capsules 
with a similar shape. They were instructed to seek other 
treatment if this treatment failed or the frequency of 
vomiting exceeded five times a day. Every participant re-
ceived 14 copies of the Rhodes Index form. They also re-
ceived instructions to complete the form every 12 hours, 
and to record the intensity of the signs (nausea, vomit-
ing, and retching). This form included eight items that 
described the signs using a Likert scale ranging from 
mild (0) to very severe (4), with a maximum total score of 
32. The patient evaluated the syndrome every 12 hours on 
a 5-point scale (21). This instrument has been used pre-
viously in several researches in Iran (8, 22), and in other 
countries (23, 24). In Iran, its validity was confirmed by 
content validity method and its reliability was calculated 
and confirmed by a Cronbach's alpha (α = 0.898) (23). In 
addition, its reliability was acceptable in other countries 
(with Cronbach’s alphas of 0.77 in the United Kingdom, 
0.897 in the USA, and 0.929 in China) (25-27). 
Every participant in the ginger group received twelve 250 
mg ginger capsules produced by Gol Daro Co. (Zintoma 
trade mark). They were instructed to take three capsules 
per day, for four days. Similar instructions were given to the 
placebo group. The researcher contacted every participant 
twice during the study. Once on the fourth day to answer 
the women's questions in the three groups and to ask them 
to start the recommended method. Then again on the sev-
enth day to thank the participants for their participation in 
the study and to request that they return the Rhodes Index 
forms for evaluation of their responses to the treatment. 
NVP was evaluated using the Rhodes Index scores. 
The hypothesis tested was whether ginger resulted in a re-
duction of nausea, vomiting and retching symptoms. These 
were indicated by a mean reduction of Rhodes Index scores. 
3.1. Ethical Considerations
Eligible women consented to participate in this study 
(1). The benefits, risks and effectiveness of the new inter-
vention were described for the women (2). The privacy of 
the women and their personal information were protect-
ed during the study (3). The women were asked to start a 
medication if the advised treatment failed, or vomiting 
was more than five times per day (4). The women were 
informed about the results at the end of the study (5). 
3.2. Data Analysis
Results were calculated by the mean Rhodes Index scores 
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in the pre-intervention (three days before the intervention), 
minus the mean Rhodes Index scores in the post interven-
tion (four days after the intervention), and then compared 
in the three groups by an ANOVA test. We checked the nor-
mal distribution of variables. The ANOVA and Kruskal-Wallis 
tests were used for normal and non-normal variables re-
spectively. A Chi-square test was performed for the qualita-
tive variables. An ANCOVA test was used to control for con-
founding variables. A significance level of P < 0.05 was used 
for all tests. To determine the sample size, a pilot study was 
conducted on 10 subjects in the ginger and placebo groups, 
the mean reduction of Rhodes Index scores in the ginger 
and placebo groups were; 7.5 and 3.5 on the Rhodes Index. 
Thus, the needed sample size with a significance level of 5%, 
and power of 90%, was calculated to be 33 in each group. 
Considering a 10% dropout rate, 40 subjects per group were 
recruited to the study. 
4. Results
All of the women were included in the intention to 
treat (ITT) analysis. During the study, 431 pregnant 
women were screened, and among them, 120 women 
were recruited, and 311 were excluded from the study. In 
the ginger group, one woman had heartburn when she 
took the ginger capsules, one woman used other medi-
cation and one woman did not return to the clinic. In 
the placebo group, two women used other medications 
and two women did not return to the clinic. In the con-
trol group, five women used other medications and two 
women did not return to the clinic. These women were 
excluded from the study. Finally, there were 37 women 
in the ginger, 36 in the placebo, and 33 in the control 
groups. Analyses were performed on a total of 106 wom-
en (Figure 1).  
Figure 1. Trial Profile of Recruitment and Randomization to Ginger, Placebo or Control Groups
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There were no statistical differences in the baseline de-
mographics (age, gestational age (weeks), occupation, and 
level of education) between the three groups apart from; 
age of marriage (P < 0.017), and wanted or unwanted preg-
nancy (P < 0.027) (Table 1). We compared the mean reduc-
tion Rhodes Index scores between the three groups. The 
resulting scores were significantly greater in the ginger 
group than in the placebo and control groups. An ANOVA 
test showed that there were significant differences in the 
mean reduction of Rhodes Index scores in; vomiting, nau-
sea, retching and total scores between the three groups 
(P<0.001) (Table 2). A Tukey’s post hoc test was performed 
and the results showed a significant difference between 
the three groups in the mean reduction of; vomiting, nau-
sea, retching and total Rhodes Index scores (P <0.001). An 
ANCOVA test (covariance test) showed that after control-
ling for the effects of; age of marriage and wanted or un-
wanted pregnancy; there were still significant differences 
in the mean scores of the Rhodes Index after the interven-
tion in the three groups. The percentage reductions for the 
total Rhodes Index scores were; 48% when using ginger, 13% 
for the placebo, and -10% in the control (Table 3). 
Table 1.  Baseline Characteristics of the Patients
Characteristics Ginger, n = 40 Placebo, n = 40 Control, n = 40 P value
Age, mean ± SD, y 27.35 ± 5.93 26.85 ± 4.90 25.95 ± 3.46 0.431 a
Age of marriage mean 
± SD, y
18.9 ± 2.97 20.47 ± 3.34 19.32 ± 1.95 0.02 b
Gestational age, wk 8.97 ± 0.05 9.85 ± 2.27 9.30 ± 2.37 0.24 a
Occupation, No. (%) 0.578 c
Employee 2 (5) 4 (10) 2 (5)
Housewife 38 (95) 36 (90) 38 (95)
Parity, No. (%) 0.10 d
Nulliparous 12 (30) 20 (50) 13 (32.5)
Multiparous 28 (70) 20 (50) 29 (77.5)
Pregnancy, No. (%) 0.027d
Wanted 34 (85) 27 (67.5) 36 (90)
Unwanted 6 (15) 13 (32.5) 4 (10)
Level of education, 
No. (%)
0.457d
Lower than high 
school
12 (30 11 (27.5) 16 (40)
High school and above 28 (70) 29 (72.5) 24 (60)
a  Oneway AVONA was performed.
b  Kruskal-Wallis test was performed.
c  Fisher’s exact test was performed.
d  Chi-square test was performed.





n = 37 
Placebo, 
n = 36 
Control, 
n = 33 
P value a
Vomiting 2.52 ± 2.41 0.24 ± 2.24 0.97 ± 2.24 0.001
Nausea 3.86 ± 2.35 1.26 ± 1.57 -0.33 ± 1.74 0.001
Retching 2.15 ± 1.62 0.45 ± 1.60 -0.34 ± 1.26 0.001
Total 
score
8.53 ± 4.75 1.96 ± 4.02 -1.34 ± 3.88 0.001
a  ANOVA test was performed
Table 3.  The Percentage Reduction of Rhodes Index Scores in 
the Studied Groups
Variable, % Ginger,
n = 37 
Placebo,
n = 33 
Control,
n = 31 
Vomiting 51 0.7 -36
Nausea 46 19 -0.5
Retching 26 11 -1
Total score 48 13 -10
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5. Discussion
In this study, we determined the effect of ginger on 
nausea, vomiting and retching during the first 15 weeks 
of pregnancy using Rhodes Index forms. There are many 
studies that have provided information on both phar-
macological and non-pharmacological therapies for 
the management of this condition. Varieties of visual 
analogue scores, self-reporting tools and Rhodes Index 
forms (8, 22-24) have been used for the assessment of 
NVP in previous studies. However, in this study we used 
Rhodes Index forms. Since the age of marriage and want-
ed or unwanted pregnancy might influence the results, 
these variables were controlled by an ANCOVA test. After 
controlling for these variables, we found a significant re-
duction in the symptoms of nausea and vomiting in the 
three groups, although the improvement of nausea and 
vomiting in the ginger group was statistically greater 
than in the placebo group. 
Ozgoli found that ginger was an effective herbal rem-
edy for decreasing nausea and vomiting, and most of the 
women in the ginger group reported an improvement in 
their nausea symptoms during pregnancy (13). This study 
confirms the presence of a placebo effect in the relief of 
nausea, but it still detected some benefits of ginger in 
improving NVP. In Willetts’ study, the nausea experience 
score was significantly less for the ginger extract group 
compared to the placebo group after the first day of treat-
ment, and this difference was present on each treatment 
day. Retching was also reduced by the ginger extract, 
although to a lesser extent. No significant effect was ob-
served on vomiting (28). The reason might be due to the 
dose of ginger used in Willetts’ study, which was 500 mg 
compare to the 750 mg that was used in our study. The 
results in the present study showed that vomiting and 
nausea in the ginger group decreased by 51% and 46%, 
respectively. Total percentage reduction of Rhodes Index 
scores in the present study were; 48%, 13%, and -10%, in the 
ginger, placebo, and control groups, respectively. These 
findings indicate that ginger is more effective in treating 
nausea and vomiting than a placebo. 
In conclusion, ginger is effective in reducing NVP in 
mild to moderate symptomatic pregnant women before 
16 weeks gestation. Since this study was performed on 
mild to moderate nausea and vomiting, the results are 
not generalized to severe nausea and vomiting. The effec-
tiveness of ginger and other non-pharmacological thera-
pies such as acupressure in relieving severe NVP could be 
investigated in future clinical trials. 
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